TrialClinical pharmacokinetics2017

Impact of Venetoclax Exposure on Clinical Efficacy and Safety in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia.

Kevin J Freise et al.PubMed ↗Publisher ↗

No numbers read from the abstract.